Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ocugen Inc (NQ: OCGN )

1.330 +0.050 (+3.91%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Ocugen Inc

< Previous 1 2
...
15 16 17 18 19 20 21 22 Next >
Better Short-Squeeze Stock: Clover Health or Ocugen?
Both have the necessary ingredients for explosive short-squeeze returns. 
Via The Motley Fool
Why Ocugen Shares Are Slipping Today
It could be due to the aftereffects of being included in a major stock index. 
Via The Motley Fool
Sell Ocugen Stock Before the Other Shoe Finally Drops
The bad news with Covaxin hasn't sunk in yet with OCGN stock investors, so get out while the stock still remains elevated. 
Via InvestorPlace
Exposures COVID-19
What's Going On With Ocugen (OCGN) Stock Today?
Ocugen Inc (NASDAQ: OCGN) shares are trading 1.6% higher in the pre-market session on Wednesday amid high social media interest. The company's shares had closed nearly 2%... 
Via Benzinga
If Ocugen Stock Is Worth $8, I’ll Eat My Hat
OCGN stock at $8.35 looks ridiculously overvalued given the change in course 
Via InvestorPlace
Exposures COVID-19
What's Next For Ocugen Stock As It Bounces Off Support?
Ocugen Inc. (NASDAQ:OCGN) shares are trading lower Tuesday... 
Via Benzinga
Ocugen Stock Is A Bust After Covaxin’s Emergency Use Rejection
OCGN stock is of no value to investors now that federal regulators closed the door on its Covid-19 vaccine commercialization efforts. 
Via InvestorPlace
Exposures COVID-19 Product Safety
Is It Too Late to Buy Ocugen Stock?
The company has found a partner to manufacture its COVID-19 vaccine -- but will it be all for naught? 
Via The Motley Fool
Exposures COVID-19
Get Rid of Ocugen Stock While You Can as the Bad News Piles Up
After OCGN stock rallied due to factors that were not based on fundamentals, investors should sell the shares. 
Via InvestorPlace
Exposures COVID-19
Why Ocugen Climbed 8% Higher Today
The company will join a rarefied club starting early next week. 
Via The Motley Fool
3 Obscenely Overpriced Stocks I Wouldn't Buy Even if the Market Crashes
A lower price won't address these other risks. 
Via The Motley Fool
If You Invested $10,000 in Ocugen in December, This Is How Much You Would Have Today
Now the question is: Can your investment grow from here? 
Via The Motley Fool
Exposures COVID-19
2 Stocks That Are Running Circles Around Bitcoin This Year
Can they keep outpacing the popular cryptocurrency? 
Via The Motley Fool
It’s Time to Admit Defeat and Dump Ocugen Stock as a Covid Play
After the FDA rejected Covaxin, Ocugen has almost no chance of generating profits from the shot. OCGN stock is a great short. 
Via InvestorPlace
Exposures Product Safety
24 Stocks Moving in Wednday's Pre-Market Session
Gainers Catabasis Pharmaceuticals, Inc. (NASDAQ: CATB) rose 43.6% to $2.93 in pre-market trading after a 13G filing from Ra Capital showed a 7.5% stake in the company. Greenland... 
Via Benzinga
Avoid These 3 Overvalued Reddit Stocks
Reddit stocks Tilray, Inc., Clover Health Investments, Corp., and Ocugen, Inc., which are currently trading at high valuations, are examples of Reddit stocks that we think could retreat in the... 
Via Talk Markets
Novavax COVID-19 Vaccine Could Become Available In India By September, Says Partner
Novavax Inc (NASDAQ: NVAX) COVID-19 vaccine, marketed as "Covovax," could see a launch in India as early as September, Moneycontrol reported on Wednesday... 
Via Benzinga
Exposures COVID-19
OCGN Stock: Ocugen Fans Should Be Cheering This COVAXIN News
OCGN stock saw a glimmer of hope today. Where the company took a hit last week in deserting EUA, it is gaining today with a new partnership. 
Via InvestorPlace
Exposures COVID-19 Product Safety
Why Ocugen Stock Rallied Today
The biotech is bolstering its production capabilities for an experimental coronavirus vaccine. 
Via The Motley Fool
Exposures COVID-19
34 Stocks Moving In Tuesday's Mid-Day Session
Gainers HMG/Courtland Properties, Inc. (NYSE: HMG) shares surged 133% to $27.80. Alfi, Inc. (NASDAQ: ALF) shares jumped 82.1% to $6.21 after the company inked an agreement with... 
Via Benzinga
Ocugen Stock Jumps After Recruiting Jubilant HollisterStier As Manufacturing Partner For COVID-19 Vaccine Candidate
Ocugen Inc (NASDAQ: OCGN) has selected Jubilant HollisterStier of Spokane, Washington as its manufacturing partner for COVID-19 vaccine candidate, Covaxin for the... 
Via Benzinga
Exposures COVID-19
Thinking About Buying Stock Or Options In Royal Caribbean Group, Ocugen Or Spirit Airlines?
Royal Caribbean Cruises Ltd (NYSE:RCL) Tuesday announced that... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Clearside Biomedical (NASDAQ:CLSD) stock increased by 50.99% to $4.56 during Tuesday's pre-market session. The market value of their outstanding shares is at $... 
Via Benzinga
Ocugen Stock Crashes: What Should Investors Do Now?
Here are three steps to take. 
Via The Motley Fool
Exposures COVID-19 Product Safety
Will This News Stop Ocugen Shares in Their Tracks?
This high flyer is still up more than 260% this year. 
Via The Motley Fool
Exposures COVID-19
Where Will Ocugen Be in 1 Year?
This biotech underdog's dream of selling a coronavirus vaccine in the U.S. just went up in smoke. 
Via The Motley Fool
Exposures COVID-19
Benzinga's Top Ratings Upgrades, Downgrades For June 11, 2021
Upgrades Barclays upgraded the previous rating for Ventas Inc (NYSE:VTR) from Equal-Weight to Overweight. In the first quarter, Ventas showed an EPS of $0.72, compared to... 
Via Benzinga
10 Biggest Price Target Changes For Friday
Barclays lowered Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) price target from $302 to $285. Vertex Pharmaceuticals shares fell 13.3% to $187.88 in pre-market trading.... 
Via Benzinga
66 Biggest Movers From Yesterday
Gainers Orphazyme A/S (NASDAQ: ORPH) shares jumped 302.3% to close at $21.00 on Thursday. Shares of the biopharmaceutical firm touched an intraday high of $77.77, running up 1,... 
Via Benzinga
Why Ocugen Plummeted by Nearly 30% Today
The company won't be getting emergency use authorization for Covaxin after all. 
Via The Motley Fool
Exposures COVID-19 Product Safety
< Previous 1 2
...
15 16 17 18 19 20 21 22 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.